In contrast, fatty acid synthase (FAS) expression was not decreased in NAFLD, despite IRS-2 downregulation, but correlated strongly with IRS-1 expression. The gene discussed is IRS2; the disease is metabolic dysfunction-associated steatotic liver disease.